236 related articles for article (PubMed ID: 16243825)
21. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells.
Nojima K; Hochegger H; Saberi A; Fukushima T; Kikuchi K; Yoshimura M; Orelli BJ; Bishop DK; Hirano S; Ohzeki M; Ishiai M; Yamamoto K; Takata M; Arakawa H; Buerstedde JM; Yamazoe M; Kawamoto T; Araki K; Takahashi JA; Hashimoto N; Takeda S; Sonoda E
Cancer Res; 2005 Dec; 65(24):11704-11. PubMed ID: 16357182
[TBL] [Abstract][Full Text] [Related]
22. Functional interplay between BRCA2/FancD1 and FancC in DNA repair.
Kitao H; Yamamoto K; Matsushita N; Ohzeki M; Ishiai M; Takata M
J Biol Chem; 2006 Jul; 281(30):21312-21320. PubMed ID: 16687415
[TBL] [Abstract][Full Text] [Related]
23. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
Snyder ER; Ricker JL; Chen Z; Waes CV
Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
25. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells.
Marathi UK; Howell SR; Ashmun RA; Brent TP
Blood; 1996 Sep; 88(6):2298-305. PubMed ID: 8822951
[TBL] [Abstract][Full Text] [Related]
26. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.
De Toni EN; Ziesch A; Rizzani A; Török HP; Hocke S; Lü S; Wang SC; Hucl T; Göke B; Bruns C; Gallmeier E
Oncotarget; 2016 Feb; 7(8):9477-90. PubMed ID: 26843614
[TBL] [Abstract][Full Text] [Related]
28. Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs.
Ueda F; Sumi K; Tago K; Kasahara T; Funakoshi-Tago M
Cell Signal; 2013 Nov; 25(11):2115-24. PubMed ID: 23838005
[TBL] [Abstract][Full Text] [Related]
29. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
30. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.
Ghosh S; Sur S; Yerram SR; Rago C; Bhunia AK; Hossain MZ; Paun BC; Ren YR; Iacobuzio-Donahue CA; Azad NA; Kern SE
Am J Pathol; 2014 Jan; 184(1):260-70. PubMed ID: 24200853
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
[TBL] [Abstract][Full Text] [Related]
33. Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.
Villarroel MC; Rajeshkumar NV; Garrido-Laguna I; De Jesus-Acosta A; Jones S; Maitra A; Hruban RH; Eshleman JR; Klein A; Laheru D; Donehower R; Hidalgo M
Mol Cancer Ther; 2011 Jan; 10(1):3-8. PubMed ID: 21135251
[TBL] [Abstract][Full Text] [Related]
34. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
[TBL] [Abstract][Full Text] [Related]
35. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.
Martínez S; Pérez L; Galmarini CM; Aracil M; Tercero JC; Gago F; Albella B; Bueren JA
Br J Pharmacol; 2013 Oct; 170(4):871-82. PubMed ID: 23937566
[TBL] [Abstract][Full Text] [Related]
37. Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin.
Casado JA; Río P; Marco E; García-Hernández V; Domingo A; Pérez L; Tercero JC; Vaquero JJ; Albella B; Gago F; Bueren JA
Mol Cancer Ther; 2008 May; 7(5):1309-18. PubMed ID: 18483318
[TBL] [Abstract][Full Text] [Related]
38. Evidence for subcomplexes in the Fanconi anemia pathway.
Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
Hess CJ; Ameziane N; Schuurhuis GJ; Errami A; Denkers F; Kaspers GJ; Cloos J; Joenje H; Reinhardt D; Ossenkoppele GJ; Zwaan CM; Waisfisz Q
Cell Oncol; 2008; 30(4):299-306. PubMed ID: 18607065
[TBL] [Abstract][Full Text] [Related]
40. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.
Pang Q; Keeble W; Diaz J; Christianson TA; Fagerlie S; Rathbun K; Faulkner GR; O'Dwyer M; Bagby GC
Blood; 2001 Mar; 97(6):1644-52. PubMed ID: 11238103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]